Brief: Rhythm Biosciences Enters Service Agreement At Memorial Sloan Kettering Cancer Center
24/07/2025 02:39
July 24 (Reuters) - Rhythm Biosciences Ltd RHY.AX: SERVICE AGREEMENT TO SUPPORT CLINICAL TRIALS AT MEMORIAL SLOAN KETTERING CANCER CENTER Further company coverage: RHY.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Rhythm Biosciences
See all newsBrief: Rhythm Biosciences Says Gavin Fox-Smith Resigns As Chair
Brief: Rhythm Biosciences Announces Appointment Of Non-Executive Directors
Australia's Rhythm Biosciences rises on accelerating commercialisation of cancer test
Brief: Rhythm Biosciences Executes Distribution Agreement For Genetype
Brief: Rhythm Biosciences Seeks Trading Halt